Pharma Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Prostate Cancer

Cell Genesys Reports Fourth Quarter and Full Year 2006 Results

For the fourth quarter of 2006, the company reported a net loss of $30.3 million, or $0.54 per fully diluted share, compared with net income of $19.1 million, or $0.33 per fully diluted share, for the same period in 2005. The increase in net loss in the current quarter is attributed primarily to the absence of gains from sales of marketable securities compared to the fourth quarter of 2005, at which time the company had a gain of $48.8 million from the sale of 3.0 million shares of common stock of Abgenix, its former subsidiary.

...

• View Other Issues of Pharma Business Week
  
• View Other NewsRx Publications